Vanguard Group Inc. Reduces Holdings in Amedisys, Inc. $AMED

Key Points

• Vanguard Group Inc. reduced its stake in Amedisys, Inc. by 0.6% in Q1, now owning approximately 9.74% of the company's shares, valued at $296.19 million.
• Amedisys reported earnings of $1.54 per share, surpassing analysts' expectations of $1.39, with a revenue of $621.86 million for the quarter, a 5.2% increase year-over-year.
• Following recent evaluations, Wall Street Zen downgraded Amedisys from a "strong-buy" to a "buy" rating on May 24th.

Vanguard Group Inc. lowered its stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 0.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,197,511 shares of the health services provider's stock after selling 18,609 shares during the quarter. Vanguard Group Inc. owned 9.74% of Amedisys worth $296,185,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of AMED. Hexagon Capital Partners LLC grew its holdings in Amedisys by 108.1% during the first quarter. Hexagon Capital Partners LLC now owns 310 shares of the health services provider's stock worth $29,000 after buying an additional 161 shares in the last quarter. MassMutual Private Wealth & Trust FSB grew its holdings in Amedisys by 56.1% during the first quarter. MassMutual Private Wealth & Trust FSB now owns 334 shares of the health services provider's stock worth $31,000 after buying an additional 120 shares in the last quarter. Fifth Third Bancorp grew its holdings in Amedisys by 68.1% during the first quarter. Fifth Third Bancorp now owns 348 shares of the health services provider's stock worth $32,000 after buying an additional 141 shares in the last quarter. UMB Bank n.a. grew its holdings in Amedisys by 100.0% during the first quarter. UMB Bank n.a. now owns 386 shares of the health services provider's stock worth $36,000 after buying an additional 193 shares in the last quarter. Finally, Johnson Financial Group Inc. bought a new stake in Amedisys during the fourth quarter worth $55,000. Institutional investors own 94.36% of the company's stock.

Amedisys Stock Performance

NASDAQ:AMED traded up $0.03 during trading on Friday, reaching $101.01. The company's stock had a trading volume of 1,060,057 shares, compared to its average volume of 780,222. The firm has a market cap of $3.32 billion, a price-to-earnings ratio of 39.30, a price-to-earnings-growth ratio of 1.34 and a beta of 0.89. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.36 and a current ratio of 1.36. The firm has a 50 day moving average of $98.47 and a 200-day moving average of $95.02. Amedisys, Inc. has a 12 month low of $82.15 and a 12 month high of $101.02.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The health services provider reported $1.54 EPS for the quarter, beating analysts' consensus estimates of $1.39 by $0.15. Amedisys had a return on equity of 12.91% and a net margin of 3.56%.The firm had revenue of $621.86 million for the quarter, compared to analysts' expectations of $614.61 million. During the same quarter in the prior year, the firm earned $0.98 EPS. The business's revenue for the quarter was up 5.2% compared to the same quarter last year. Research analysts expect that Amedisys, Inc. will post 4.4 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen downgraded Amedisys from a "strong-buy" rating to a "buy" rating in a report on Saturday, May 24th. One investment analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $100.50.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.